TP53 oncomorphic mutations predict resistance to platinum and taxanebased standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma

By  

International Journal of Oncology, Vol. 46, Iss. 2, 2015-01 ,pp. : 607-618

Spandidos Publications

Access to resources Recommend Favorite

Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma - influence of tumour site, stage, adjuvant chemotherapy and type of mutation

By Soong R.   Powell B.   Elsaleh H.   Gnanasampanthan G.   Smith D.R.   Goh H.S.   Joseph D.   Iacopetta B.  

European Journal of Cancer, Vol. 36, Iss. 16, 2000-10 ,pp. : 2053-2060

Elsevier

Access to resources Recommend Favorite

TP53 mutation is rare in primary myelofibrosis

By Greaves Wesley O.  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1552-1552

Informa Healthcare

Access to resources Recommend Favorite

p53 Gene Mutation Analysis and Antisense-Mediated Growth Inhibition of Human Ovarian Carcinoma Cell Lines

By Skilling J.S.   Squatrito R.C.   Connor J.P.   Niemann T.   Buller R.E.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 72-80

Academic Press

Access to resources Recommend Favorite

TP53 Pro72 allele potentially increases the poor prognostic significance of TP53 mutation in chronic lymphocytic leukemia

By Dong Hua-Jie   Fang Cheng   Wang Li   Fan Lei   Xu Ji   Wu Jia-Zhu   Lu Ting-Xun   Li Jian-Yong   Xu Wei  

Medical Oncology, Vol. 31, Iss. 4, 2014-04 ,pp. : 1-10

Humana Press, Inc

Access to resources Recommend Favorite